{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Telomir Pharmaceuticals, Inc.
Is Telomir Pharmaceuticals, Inc. technically bullish or bearish?
As of June 5, 2025, the technical trend is bearish with moderate strength, driven by bearish signals from the MACD, KST, and moving averages, despite a bullish RSI, indicating a prevailing negative sentiment and underperformance compared to the S&P 500.
What does Telomir Pharmaceuticals, Inc. do?
Telomir Pharmaceuticals, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $2 million and a market cap of $55.36 million. Key metrics include a debt equity ratio of 0.40 and a return on equity of 1,653.27%.
How big is Telomir Pharmaceuticals, Inc.?
As of Jun 18, Telomir Pharmaceuticals, Inc. has a market capitalization of 55.36 million, with net sales of 0.00 million and a net profit of -12.52 million over the last four quarters. The company's shareholder's funds are 0.64 million, and total assets are 1.32 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
